163 related articles for article (PubMed ID: 24963495)
1. Loss of insulin receptor in osteoprogenitor cells impairs structural strength of bone.
Thrailkill K; Bunn RC; Lumpkin C; Wahl E; Cockrell G; Morris L; Kahn CR; Fowlkes J; Nyman JS
J Diabetes Res; 2014; 2014():703589. PubMed ID: 24963495
[TBL] [Abstract][Full Text] [Related]
2. Postnatal loss of the insulin receptor in osteoprogenitor cells does not impart a metabolic phenotype.
Fowlkes JL; Clay Bunn R; Kalaitzoglou E; Ray P; Popescu I; Thrailkill KM
Sci Rep; 2020 Jun; 10(1):8842. PubMed ID: 32483283
[TBL] [Abstract][Full Text] [Related]
3. Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action.
Fulzele K; DiGirolamo DJ; Liu Z; Xu J; Messina JL; Clemens TL
J Biol Chem; 2007 Aug; 282(35):25649-58. PubMed ID: 17553792
[TBL] [Abstract][Full Text] [Related]
4. Reduced trabecular bone mass and strength in mice overexpressing Gα11 protein in cells of the osteoblast lineage.
Dela Cruz A; Mattocks M; Sugamori KS; Grynpas MD; Mitchell J
Bone; 2014 Feb; 59():211-22. PubMed ID: 24308950
[TBL] [Abstract][Full Text] [Related]
5. Female mice lacking estrogen receptor-alpha in osteoblasts have compromised bone mass and strength.
Melville KM; Kelly NH; Khan SA; Schimenti JC; Ross FP; Main RP; van der Meulen MC
J Bone Miner Res; 2014 Feb; 29(2):370-9. PubMed ID: 24038209
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Gα
Zhang L; Sugamori KS; Claridge C; Dela Cruz A; Grynpas MD; Mitchell J
J Bone Miner Res; 2017 Nov; 32(11):2171-2181. PubMed ID: 28727179
[TBL] [Abstract][Full Text] [Related]
7. Lrp5 and Lrp6 exert overlapping functions in osteoblasts during postnatal bone acquisition.
Riddle RC; Diegel CR; Leslie JM; Van Koevering KK; Faugere MC; Clemens TL; Williams BO
PLoS One; 2013; 8(5):e63323. PubMed ID: 23675479
[TBL] [Abstract][Full Text] [Related]
8. Targeted disruption of nuclear factor erythroid-derived 2-like 1 in osteoblasts reduces bone size and bone formation in mice.
Kim J; Xing W; Wergedal J; Chan JY; Mohan S
Physiol Genomics; 2010 Jan; 40(2):100-10. PubMed ID: 19887580
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of IKK2/NF-κB impairs osteogenesis and skeletal development.
Swarnkar G; Zhang K; Mbalaviele G; Long F; Abu-Amer Y
PLoS One; 2014; 9(3):e91421. PubMed ID: 24618907
[TBL] [Abstract][Full Text] [Related]
10. Jagged1 expression by osteoblast-lineage cells regulates trabecular bone mass and periosteal expansion in mice.
Youngstrom DW; Dishowitz MI; Bales CB; Carr E; Mutyaba PL; Kozloff KM; Shitaye H; Hankenson KD; Loomes KM
Bone; 2016 Oct; 91():64-74. PubMed ID: 27416809
[TBL] [Abstract][Full Text] [Related]
11. Insulin receptor isoforms are differently expressed during human osteoblastogenesis.
Avnet S; Perut F; Salerno M; Sciacca L; Baldini N
Differentiation; 2012 Jun; 83(5):242-8. PubMed ID: 22466604
[TBL] [Abstract][Full Text] [Related]
12. Targeting of androgen receptor in bone reveals a lack of androgen anabolic action and inhibition of osteogenesis: a model for compartment-specific androgen action in the skeleton.
Wiren KM; Semirale AA; Zhang XW; Woo A; Tommasini SM; Price C; Schaffler MB; Jepsen KJ
Bone; 2008 Sep; 43(3):440-51. PubMed ID: 18595795
[TBL] [Abstract][Full Text] [Related]
13. The effect of conditional inactivation of beta 1 integrins using twist 2 Cre, Osterix Cre and osteocalcin Cre lines on skeletal phenotype.
Shekaran A; Shoemaker JT; Kavanaugh TE; Lin AS; LaPlaca MC; Fan Y; Guldberg RE; García AJ
Bone; 2014 Nov; 68():131-41. PubMed ID: 25183373
[TBL] [Abstract][Full Text] [Related]
14. Rictor/mTORC2 loss in osteoblasts impairs bone mass and strength.
Liu DM; Zhao L; Liu TT; Jiao PL; Zhao DD; Shih MS; Tao B; Sun LH; Zhao HY; Liu JM
Bone; 2016 Sep; 90():50-8. PubMed ID: 27262777
[TBL] [Abstract][Full Text] [Related]
15. Transgenic Expression of Osteoactivin/gpnmb Enhances Bone Formation In Vivo and Osteoprogenitor Differentiation Ex Vivo.
Frara N; Abdelmagid SM; Sondag GR; Moussa FM; Yingling VR; Owen TA; Popoff SN; Barbe MF; Safadi FF
J Cell Physiol; 2016 Jan; 231(1):72-83. PubMed ID: 25899717
[TBL] [Abstract][Full Text] [Related]
16. N-cadherin and cadherin 11 modulate postnatal bone growth and osteoblast differentiation by distinct mechanisms.
Di Benedetto A; Watkins M; Grimston S; Salazar V; Donsante C; Mbalaviele G; Radice GL; Civitelli R
J Cell Sci; 2010 Aug; 123(Pt 15):2640-8. PubMed ID: 20605916
[TBL] [Abstract][Full Text] [Related]
17. Fkbp10 Deletion in Osteoblasts Leads to Qualitative Defects in Bone.
Lietman CD; Lim J; Grafe I; Chen Y; Ding H; Bi X; Ambrose CG; Fratzl-Zelman N; Roschger P; Klaushofer K; Wagermaier W; Schmidt I; Fratzl P; Rai J; Weis M; Eyre D; Keene DR; Krakow D; Lee BH
J Bone Miner Res; 2017 Jun; 32(6):1354-1367. PubMed ID: 28206698
[TBL] [Abstract][Full Text] [Related]
18. Role of reduced insulin-stimulated bone blood flow in the pathogenesis of metabolic insulin resistance and diabetic bone fragility.
Hinton PS
Med Hypotheses; 2016 Aug; 93():81-6. PubMed ID: 27372862
[TBL] [Abstract][Full Text] [Related]
19. Enhancer of zeste homolog 2 (
Dudakovic A; Camilleri ET; Paradise CR; Samsonraj RM; Gluscevic M; Paggi CA; Begun DL; Khani F; Pichurin O; Ahmed FS; Elsayed R; Elsalanty M; McGee-Lawrence ME; Karperien M; Riester SM; Thaler R; Westendorf JJ; van Wijnen AJ
J Biol Chem; 2018 Aug; 293(33):12894-12907. PubMed ID: 29899112
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of Macf1 in osterix expressing cells decreases bone formation by Bmp2/Smad/Runx2 pathway.
Qiu WX; Ma XL; Lin X; Zhao F; Li DJ; Chen ZH; Zhang KW; Zhang R; Wang P; Xiao YY; Miao ZP; Dang K; Wu XY; Qian AR
J Cell Mol Med; 2020 Jan; 24(1):317-327. PubMed ID: 31709715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
